Centre agrees to increase gap between two doses of Covishield to 12-16 weeks
The present gap between two doses of Covishield, manufactured by the Serum Institute of India, is 6-8 weeks.
Share Via Email
| A+A A-
A medic administers COVID-19 vaccine to a beneficiary amid the second wave of coronavirus epidemic, in New Delhi. (Photo | PTI) By PTI
NEW DELHI: The Centre on Thursday approved extending the gap between the two doses of the Covishield vaccine from 6-8 weeks to 12-16 weeks following a recommendation from a government panel, the Union health ministry said.
However, the National Technical Advisory Group on Immunisation (NTAGI) has suggested no change for the dosage interval for Covaxin, the ministry said.
3755
New Delhi, May 13
The Centre on Thursday approved extending the gap between the two doses of the Covishield vaccine to 12-16 weeks following a recommendation from a government panel, and said it is a “science-based decision” taken with confidence that there will be no extra risk.
However, the National Technical Advisory Group on Immunisation (NTAGI) has suggested no change for the dosage interval for Covaxin, the Union health ministry said.
“Based on the available real-life evidences, particularly from the UK, the COVID-19 Working Group agreed for increasing the dosing interval to 12-16 weeks between two doses of Covishield vaccine. No change in interval of Covaxin vaccine doses was recommended,” the ministry said.